They have created virtual companies to develop novel compounds in various therapeutic areas, focusing on early stage development. With a small internal team, they provide drug development services to these virtual companies through vendors and CROs. Their expertise allows them to quickly progress compounds through key milestones, reducing risk. Drais Pharmaceuticals acquires and develops pharmaceutical compounds across different therapeutic areas, aiming to deliver value to patients, physicians, and stakeholders. Their management team consists of experienced individuals dedicated to developing novel treatments that address unmet medical needs.